Trigone as a diagnostic and therapeutic target for bladder-centric interstitial cystitis/bladder pain syndrome

被引:8
|
作者
Dobberfuhl, Amy D. [1 ]
van Uem, Stefanie [1 ]
Versi, Eboo [2 ]
机构
[1] Stanford Univ, Sch Med, Dept Urol, 300 Pasteur Dr,Grant S-287, Stanford, CA 94305 USA
[2] Rutgers Robert Wood Johnson Med Sch, Dept Obstet Gynecol & Reprod Sci, 125 Paterson St, New Brunswick, NJ 08901 USA
基金
美国国家卫生研究院;
关键词
Female; Interstitial cystitis; Urinary bladder; Afferent pathways; Type A botulinum toxins; Local anesthetics; CURRENT PERCEPTION THRESHOLD; DETRUSOR OVERACTIVITY; WALL THICKNESS; INJECTION;
D O I
10.1007/s00192-021-04878-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS) may be bladder-centric, with afferent nerve hyperexcitability and/or due to neural central sensitization. In bladder-centric disease, the trigone's unmyelinated nociceptive C-fibers are thought to be upregulated, suggesting this as a potential target for diagnostic modalities and for treatment with local anesthetics and chemodenervation. We propose that the transvaginal trigone treatment (T3) route of administration of such treatments should be considered in women with IC/BPS, as this approach is easier and less invasive than cystoscopy. For T3, or other bladder-centric treatments to be successful, patient selection should attempt to exclude patients with predominantly neural central sensitization.
引用
收藏
页码:3105 / 3111
页数:7
相关论文
共 50 条
  • [31] Biomarkers for Bladder Pain Syndrome/Interstitial Cystitis
    Ana Charrua
    Pedro Mendes
    Célia Cruz
    Current Bladder Dysfunction Reports, 2021, 16 : 12 - 18
  • [32] Coping With Interstitial Cystitis/Bladder Pain Syndrome
    Sutherland, Susanna
    Kelly, A. Grace
    McKernan, Lindsey C.
    Dmochowski, Roger R.
    Reynolds, William Stuart
    Sebesta, Elisabeth M.
    NEUROUROLOGY AND URODYNAMICS, 2024, 43 (08) : 1895 - 1902
  • [33] Pharmacotherapy for Interstitial Cystitis/Bladder Pain Syndrome
    Greiman, Alyssa
    Cox, Lindsey
    CURRENT BLADDER DYSFUNCTION REPORTS, 2019, 14 (04) : 365 - 376
  • [34] Understanding bladder pain syndrome/interstitial cystitis
    Visha Tailor
    Marco Torella
    Valentin Manriquez
    Giuseppe Alessandro Digesu
    International Urogynecology Journal, 2020, 31 : 1495 - 1496
  • [35] Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function
    Mostafa M. Mostafa
    Mostafa Kamel
    Mohamed Kamel
    Ayman Mahdy
    Current Bladder Dysfunction Reports, 2024, 19 : 16 - 26
  • [36] Chronic bladder diseases: overactive bladder and interstitial cystitis/bladder pain syndrome
    Yoon, Hana
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (11): : 763 - 769
  • [37] Interstitial Cystitis/Bladder Pain Syndrome: Role of Bladder Inflammation in Bladder Function
    Mostafa, Mostafa M.
    Kamel, Mostafa
    Kamel, Mohamed
    Mahdy, Ayman
    CURRENT BLADDER DYSFUNCTION REPORTS, 2024, 19 (01) : 16 - 26
  • [38] Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome EDITORIAL COMMENT REPLY
    不详
    JOURNAL OF UROLOGY, 2017, 198 (02): : 375 - 375
  • [39] Small Fiber Polyneuropathy Is Associated With Non-Bladder-Centric Interstitial Cystitis/Bladder Pain Syndrome Patients
    Overholt, Tyler L.
    Matthews, Catherine A.
    Evans, Robert J.
    Badlani, Gopal
    Ahn, Christine
    Simon, Trang
    Walker, Stephen J.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (09): : 581 - 585
  • [40] Bruton tyrosine kinase (BTK) may be a potential therapeutic target for interstitial cystitis/bladder pain syndrome
    Wang, Guang
    Yang, Tong-Xin
    Li, Jiong-Ming
    Huang, Zi-Ye
    Yang, Wen-Bo
    Li, Pei
    He, Da-Lin
    AGING-US, 2022, 14 (17): : 7052 - 7064